2 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Lacerations: new trials by email Literature Review of Lacerations trials Research Report on Lacerations
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Feasibility of ADRCs (Adipose Derived Regenerative Cells) in Patients With Grade II Hamstring Tears ADRCs prepared by investigational Celution Device, Placebo - Muscle Tear | Phase 1 / Phase 2 | Withdrawn | Cytori Therapeutics | 2014-01-01 | 2014-11-21 | |
| Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel Cyclosporine Eye Drops (Restasis), Lubricant Eye Drops (Refresh Endura™), Fluorometholone Eye Drops (FML Forte®) - Epiphora | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2009-06-01 | 2012-08-02 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Endophthalmitis (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1) · Lacrimal Apparatus Diseases (1) · Lung Neoplasms (1) · Ovarian Neoplasms (1) · Platelet Glycoprotein IV Deficiency (1) · Prostatic Neoplasms (1) · Small Cell Lung Carcinoma (1) · Stomach Neoplasms (1) · Urinary Bladder Neoplasms (1)
Wounds and Injuries (2) · Adnexal Diseases (1) · Breast Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Esophageal Diseases (1) · Eye Diseases (1) · Eye Infections (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1)
Cyclosporins (1) · Fluorometholone (1) · Lubricant Eye Drops (1)
Cytori Therapeutics (1) · M.D. Anderson Cancer Center (1)
United States (1)
Bita Esmaeli, MD (1) · Steven Kesten, MD (1)